Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Britannia Pharmaceuticals, a member of the STADA Arzneimittel AG group, is a prominent pharmaceutical entity headquartered in the United Kingdom. Specializing in the field of neurology, Britannia is dedicated to addressing the needs of patients with chronic and severe medical conditions, notably focusing on Parkinson’s disease. The company is renowned for its commitment to innovation, consistently striving to develop novel t...
Britannia Pharmaceuticals, a member of the STADA Arzneimittel AG group, is a prominent pharmaceutical entity headquartered in the United Kingdom. Specializing in the field of neurology, Britannia is dedicated to addressing the needs of patients with chronic and severe medical conditions, notably focusing on Parkinson’s disease. The company is renowned for its commitment to innovation, consistently striving to develop novel therapies that enhance the quality of life for individuals grappling with Parkinson's disease.

List your booth number for exhibitions, ask us